Blood pressure and risk of venous thromboembolism: a cohort analysis of 5.5 million UK adults and Mendelian randomization studies
暂无分享,去创建一个
A. Dehghan | D. Tregouet | K. Rahimi | N. Smith | M. Nazarzadeh | D. Canoy | A. Hassaine | A. Pinho-Gomes | Z. Bidel | H. Mohseni
[1] Sebastian M. Armasu,et al. Genomic and Transcriptomic Association Studies Identify 16 Novel Susceptibility Loci for Venous Thromboembolism. , 2019, Blood.
[2] K. Rahimi,et al. Systolic Blood Pressure and Risk of Valvular Heart Disease: A Mendelian Randomization Study. , 2019, JAMA cardiology.
[3] J. Gallacher,et al. Cardiovascular Risk Factors Associated With Venous Thromboembolism , 2019, JAMA cardiology.
[4] P. Donnelly,et al. The UK Biobank resource with deep phenotyping and genomic data , 2018, Nature.
[5] S. Willich,et al. Deep-vein thrombosis in Europe - Burden of illness in relationship to healthcare resource utilization and return to work. , 2018, Thrombosis research.
[6] S. Willich,et al. Pulmonary embolism in Europe - Burden of illness in relationship to healthcare resource utilization and return to work. , 2018, Thrombosis research.
[7] Christian Gieger,et al. Genetic analysis of over 1 million people identifies 535 new loci associated with blood pressure traits , 2018, Nature Genetics.
[8] M. Woodward,et al. Elevated blood pressure and risk of aortic valve disease: a cohort analysis of 5.4 million UK adults , 2018, European heart journal.
[9] G. Davey Smith,et al. Evaluating the potential role of pleiotropy in Mendelian randomization studies , 2018, Human molecular genetics.
[10] B. Neale,et al. Detection of widespread horizontal pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases , 2018, Nature Genetics.
[11] Valeriia Haberland,et al. The MR-Base platform supports systematic causal inference across the human phenome , 2018, eLife.
[12] Terence Dwyer,et al. Elevated blood pressure and risk of mitral regurgitation: A longitudinal cohort study of 5.5 million United Kingdom adults , 2017, PLoS medicine.
[13] Fernando Pires Hartwig,et al. Robust inference in summary data Mendelian randomization via the zero modal pleiotropy assumption , 2017, bioRxiv.
[14] P. Ridker,et al. Assessing the causal relationship between obesity and venous thromboembolism through a Mendelian Randomization study , 2017, Human Genetics.
[15] Olena O Yavorska,et al. MendelianRandomization: an R package for performing Mendelian randomization analyses using summarized data , 2017, International journal of epidemiology.
[16] S. Kathiresan,et al. Genetic Analysis of Venous Thromboembolism in UK Biobank Identifies the ZFPM2 Locus and Implicates Obesity as a Causal Risk Factor , 2017, Circulation. Cardiovascular genetics.
[17] J. Manson,et al. Association of Traditional Cardiovascular Risk Factors With Venous Thromboembolism: An Individual Participant Data Meta-Analysis of Prospective Studies. , 2017, Circulation.
[18] Centre , 2017 .
[19] Stephen Burgess,et al. Sensitivity Analyses for Robust Causal Inference from Mendelian Randomization Analyses with Multiple Genetic Variants , 2016, Epidemiology.
[20] Parminder Raina,et al. Maelstrom Research guidelines for rigorous retrospective data harmonization , 2016, International journal of epidemiology.
[21] F. Hartwig,et al. Two-sample Mendelian randomization: avoiding the downsides of a powerful, widely applicable but potentially fallible technique , 2016, International journal of epidemiology.
[22] D. Lawlor. Commentary: Two-sample Mendelian randomization: opportunities and challenges , 2016, International journal of epidemiology.
[23] G. Davey Smith,et al. Consistent Estimation in Mendelian Randomization with Some Invalid Instruments Using a Weighted Median Estimator , 2016, Genetic epidemiology.
[24] S. Anderson,et al. Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis , 2016, The Lancet.
[25] Mark Woodward,et al. Usual blood pressure, peripheral arterial disease, and vascular risk: cohort study of 4.2 million adults , 2015, BMJ : British Medical Journal.
[26] R. Goldberg,et al. Secular Trends in Occurrence of Acute Venous Thromboembolism: The Worcester VTE Study (1985-2009) , 2015 .
[27] G. Davey Smith,et al. Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression , 2015, International journal of epidemiology.
[28] P. Elliott,et al. UK Biobank: An Open Access Resource for Identifying the Causes of a Wide Range of Complex Diseases of Middle and Old Age , 2015, PLoS medicine.
[29] John A. Heit,et al. The epidemiology of venous thromboembolism , 2003, Journal of Thrombosis and Thrombolysis.
[30] I. White,et al. Within-person variability in calculated risk factors: Comparing the aetiological association of adiposity ratios with risk of coronary heart disease , 2013, International journal of epidemiology.
[31] J. McMurray,et al. Effect of Statins on Venous Thromboembolic Events: A Meta-analysis of Published and Unpublished Evidence from Randomised Controlled Trials , 2012, PLoS medicine.
[32] Gary King,et al. Amelia II: A Program for Missing Data , 2011 .
[33] G. Semenza. Vascular responses to hypoxia and ischemia. , 2010, Arteriosclerosis, thrombosis, and vascular biology.
[34] C. O’Donnell,et al. Mendelian randomization: nature's randomized trial in the post-genome era. , 2009, JAMA.
[35] Peter Carmeliet,et al. Regulation of angiogenesis by oxygen and metabolism. , 2009, Developmental cell.
[36] J. Heit,et al. The epidemiology of venous thromboembolism in the community. , 2008, Arteriosclerosis, thrombosis, and vascular biology.
[37] Cecilia Becattini,et al. Cardiovascular Risk Factors and Venous Thromboembolism: A Meta-Analysis , 2008, Circulation.
[38] Jordan S. Pober,et al. Evolving functions of endothelial cells in inflammation , 2007, Nature Reviews Immunology.
[39] P. Romundstad,et al. Incidence and mortality of venous thrombosis: a population‐based study , 2007, Journal of thrombosis and haemostasis : JTH.
[40] C. Kearon,et al. Natural History of Venous Thromboembolism , 2003, Circulation.
[41] L. Melton,et al. Relative impact of risk factors for deep vein thrombosis and pulmonary embolism: a population-based study. , 2002, Archives of internal medicine.
[42] A. Folsom,et al. Cardiovascular risk factors and venous thromboembolism incidence: the longitudinal investigation of thromboembolism etiology. , 2002, Archives of internal medicine.
[43] B. Line. Pathophysiology and diagnosis of deep venous thrombosis. , 2001, Seminars in nuclear medicine.
[44] G M Leydon,et al. Validation of the diagnosis of venous thromboembolism in general practice database studies. , 2000, British journal of clinical pharmacology.